Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT04911738
Recruiting Not applicable

VIrtual Reality Glasses Use to Improve Lateropulsion and the Post-stroke Postural Vertical

NCT04911738 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2021-06-15
Last updated
2025-05-21

Condition(s) studied

StrokeBrain DiseasesCerebrovascular DisordersPostural; DefectCognition Disorder

Investigational drug(s) / intervention(s)

Virtual Reality , immersion in a virtual titlted room

Virtual Reality , immersion in a virtual titlted room: The immersion in virtual reality will be based on the HTC VIVE® device and the software developed by the Virtualis Society.

Study summary

VIRGIL is a monocentric interventional study aiming to investigate the effect of immersion in a virtual tilted room on modulation of the verticality representation (postural vertical \[PV\] and visual vertical \[VV\]), which in turn might affect body orientation (head and trunk). To this end, the investigators will conduct a within-person randomized trial including post-stroke patients and healthy participants.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * 20 stroke participants * Hospitalized in neurorehabilitation * Hemisphere stroke (Right or left) * Stroke delay \< 6 months * Presence of lateropulsion assessed by the Scale for Contraversive Pushing (SCP) \> 0.5 * 20 healthy participants * No history of stroke or others neurological pathologies * No balance disorders * No history of vestibular or dizzissness disorders Exclusion Criteria: * All * History of psychiatric disorders * Nyctophobia * Advanced heart failure * Severe trunk deformation with C7 lateral \> 30 mm due to a independant cause beyond the stroke (i.e., scoliosis) or history of postural disorder * 20 Stroke participants * Medical instability making the assessment impossible * Comprehension deficits with Boston Diagnostic Aphasia Examination gravity score ≥3 * History of vestibular or dizzissness disorders * No previous neurological history interfering with balance * Inability to understand and execute simple orders * Severe untreated depression (Aphasic Depression Rating Scale (ADRS) score \>15)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Hospital Grenoble Grenoble France Recruiting

More University Hospital, Grenoble trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04911738 on ClinicalTrials.gov ↗ ← All trials in France